SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study

BACKGROUND: Immunocompromised people (ICP) and elderly individuals (older than 80 years) are at increased risk for severe coronavirus infections. To protect against serious infection with SARS-CoV-2, ICP are taking precautions that may include a reduction of social contacts and participation in acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Dopfer-Jablonka, Alexandra, Steffens, Sandra, Müller, Frank, Mikuteit, Marie, Niewolik, Jacqueline, Cossmann, Anne, Stankov, Metodi V., Behrens, Georg M. N., Hummers, Eva, Heesen, Gloria, Schröder, Dominik, Roder, Sascha, Klawonn, Frank, Vahldiek, Kai, Hasenkamp, Justin, Kallusky, Jonathan, Falk, Christine S., Overbeck, Tobias R., Heinemann, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035970/
https://www.ncbi.nlm.nih.gov/pubmed/35468758
http://dx.doi.org/10.1186/s12879-022-07347-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035970/
https://www.ncbi.nlm.nih.gov/pubmed/35468758
http://dx.doi.org/10.1186/s12879-022-07347-w

Ejemplares similares